hcplive podcasts
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.

News Network

Advancing Long-Term Arthritis Care at ACR 2020

EP. 1: Recent Achievements in Psoriatic Arthritis Management
EP. 1: Recent Achievements in Psoriatic Arthritis Management
EP. 2: Fitting Biologics into the Psoriatic Arthritis Spectrum
EP. 2: Fitting Biologics into the Psoriatic Arthritis Spectrum
EP. 3: Achieving Individualized Psoriatic Arthritis Care
EP. 3: Achieving Individualized Psoriatic Arthritis Care
EP. 4: Most Promising Psoriatic Arthritis
EP. 4: Most Promising Psoriatic Arthritis
EP. 5: Highlighted Psoriatic Arthritis Sessions at ACR 2020
EP. 5: Highlighted Psoriatic Arthritis Sessions at ACR 2020
EP. 6: How Different Psoriatic Arthritis Manifestations Affect Care
EP. 6: How Different Psoriatic Arthritis Manifestations Affect Care
EP. 7: The Modern Psoriatic Care Team
EP. 7: The Modern Psoriatic Care Team
EP. 8: The Psoriatic Patient's Role in Improving Care
EP. 8: The Psoriatic Patient's Role in Improving Care
EP. 9: What Should Highlight ACR 2021
EP. 9: What Should Highlight ACR 2021
EP. 10: Current Issues in nr-axSpA Diagnostics
EP. 10: Current Issues in nr-axSpA Diagnostics
EP. 11: Takeaways from Four-Year RAPID-axSpA Data
EP. 11: Takeaways from Four-Year RAPID-axSpA Data
EP. 12: Takeaways from the 52-Week C-axSpAnd Trial
EP. 12: Takeaways from the 52-Week C-axSpAnd Trial

Optimal Management of Rheumatic Disease During COVID-19

EP. 1: Rheumatic Disease Challenges and Goals of Therapy
EP. 1: Rheumatic Disease Challenges and Goals of Therapy
EP. 2: Psoriatic Arthritis Treatment Factors: Comorbidities
EP. 2: Psoriatic Arthritis Treatment Factors: Comorbidities
EP. 3: Data on COVID-19 in Patients With Rheumatic Disease
EP. 3: Data on COVID-19 in Patients With Rheumatic Disease
EP. 4: IL-6 Receptor Blockade in ICU Patients With COVID-19
EP. 4: IL-6 Receptor Blockade in ICU Patients With COVID-19
EP. 5: Treatment Modification: ACR COVID-19 Guidelines
EP. 5: Treatment Modification: ACR COVID-19 Guidelines
EP. 6: Accurately Diagnosing Psoriatic Arthritis
EP. 6: Accurately Diagnosing Psoriatic Arthritis
EP. 7: Guselkumab for Psoriatic Arthritis
EP. 7: Guselkumab for Psoriatic Arthritis
EP. 8: Deucravacitinib for Active Psoriatic Arthritis
EP. 8: Deucravacitinib for Active Psoriatic Arthritis
EP. 9: Treating Enthesitis in Psoriatic Arthritis Patients: Filgotinib
EP. 9: Treating Enthesitis in Psoriatic Arthritis Patients: Filgotinib
EP. 10: SELECT-PsA 1 and SELECT-PsA 2 in Psoriatic Arthritis
EP. 10: SELECT-PsA 1 and SELECT-PsA 2 in Psoriatic Arthritis

Early Initiation With LAIs to Optimally Manage Schizophrenia

EP. 1: Overview of Schizophrenia
EP. 1: Overview of Schizophrenia
EP. 2: Challenges for the Treatment of Schizophrenia
EP. 2: Challenges for the Treatment of Schizophrenia
EP. 3: Schizophrenia: Relapse Prevention and Adverse Effects
EP. 3: Schizophrenia: Relapse Prevention and Adverse Effects
EP. 4: Schizophrenia: Treatment Adherence
EP. 4: Schizophrenia: Treatment Adherence
EP. 5: Psychosocial Treatments for the Management of Schizophrenia
EP. 5: Psychosocial Treatments for the Management of Schizophrenia
EP. 6: Use of Oral Therapy for the Management of Schizophrenia
EP. 6: Use of Oral Therapy for the Management of Schizophrenia
EP. 7: Guidelines for the Treatment of Schizophrenia
EP. 7: Guidelines for the Treatment of Schizophrenia
EP. 8: Switching From Oral Therapy to Long-Acting Injectables
EP. 8: Switching From Oral Therapy to Long-Acting Injectables
EP. 9: Initiating LAI Therapy for the Treatment of Schizophrenia
EP. 9: Initiating LAI Therapy for the Treatment of Schizophrenia
EP. 10: Management of Schizophrenia and Available LAIs
EP. 10: Management of Schizophrenia and Available LAIs
EP. 11: Overcoming Barriers With LAIs in Schizophrenia Management
EP. 11: Overcoming Barriers With LAIs in Schizophrenia Management
EP. 12: Early Initiation of LAIs in Treating Schizophrenia
EP. 12: Early Initiation of LAIs in Treating Schizophrenia
EP. 13: Recommendations for Using LAIs During COVID-19
EP. 13: Recommendations for Using LAIs During COVID-19